HPV legislation in Iowa

Women in Government Ratings
Women in Government, a non-profit network of state level women legislators, receives significant funding from the pharmaceutical industry, including Merck, GlaxoSmithKline, and Digene Corporation -- all with products related to HPV vaccination and testing. According to their report, "The 'State' of Cervical Cancer Prevention in America - 2008" :

POPULATION: 2,982,085

Incidence & Mortality (2008 Score / 2007 Score)
 * Cervical Cancer Incidence Rate: 6.2/100,000 (2 / 1)
 * Cervical Cancer Incidence Rate/Race: White: 6.1, Black: 8.4, Hispanic: 11.6
 * Cervical Cancer Mortality Rate: 2.2/100,000 (1 / 1)
 * Cervical Cancer Mortality Rate/Race: White: 2.2

Screening (2008 Score / 2007 Score)
 * Cervical Cancer Screening Rate: 86.1% (2 / 2)
 * Cervical Cancer Screening Rate/Race: White: 86.3%, Hispanic: 84.5%
 * % Uninsured/Unscreened: 30.2% (0 / 0)
 * Medicaid Coverage HPV Testing: Unrestricted (2 / 2)

Healthcare Access (2008 Score / 2007 Score)
 * Rate Uninsured Women: 12% (1 / 1)
 * % Low Income/Uninsured Women: 29%

Policy Initiatives and Infrastructure (2008 Score / Cumulative Score (2005–2008)

Screening Requirements (0 / 0)
 * There are no new screening requirements.

Task Forces (0 / 0)
 * There is no new cervical cancer prevention task force legislation.

Access to HPV Vaccines (1 / 1)
 * SF 514/HF 789 would require insurers offering group or individual policies to provide coverage for the HPV vaccine; did not leave committee.

HPV Vaccine Information Programs (1 / 1)
 * SF 326/HF 661 would provide appropriations for a public awareness campaign about the HPV vaccination for vaccination of low-income persons; did not leave committee.

Miscellaneous (2 / 2)
 * SF 43 would require human sexuality education programs to include information about HPV, its link to cervical cancer and the availability of the HPV vaccine; did not leave committee.
 * HB 611 requires schools to provide students with information on HPV and the HPV vaccine; signed by Gov. Culver.

Annual Ratings
 * 2008: Good (12 out of 22 points)
 * 2007: Fair (8 out of 18 points)

SourceWatch Resources

 * Gardasil
 * GlaxoSmithKline
 * Merck
 * Women in Government
 * Edelman
 * The Marketing of Gardasil in Australia
 * The Marketing of Gardasil in Canada
 * The Marketing of Gardasil in Europe
 * The Marketing of Gardasil in New Zealand
 * The Marketing of Gardasil in the United States
 * Direct-to-consumer advertising
 * Disease Mongering
 * Drug industry